Amitabh Chandra @amitabhchandra2

Economist and Professor at HBS and HKS @Harvard. Tweets about food, dogs, piano, affogatos, India, and occasionally, health care. Harvard University Joined January 2013

Tweets

560
Followers

18K
Following

582
Likes

15K

Michael Jonas @bostonjonas

4 years ago

The controversial approval of a new $56,000-a-year #Alzheimers drug against the recommendation of an advisory committee of experts “highlights the importance of having an independent and well-resourced FDA," says @amitabhchandra2. commonwealthmagazine.org/drug-addiction…

0 2 12 0 0

Amitabh Chandra @amitabhchandra2

4 years ago

Millennials have ruined everything, everywhere. cooking.nytimes.com/recipes/102009…

12 3 59 0 1

NBER @nberpubs

4 years ago

While FDA review is often described as increasing costs and perhaps slowing flow of new products, by certifying quality, this review can grow market size and innovation incentives, from Benjamin Berger, @amitabhchandra2, and @C_Garthwaite nber.org/papers/w28889

0 10 16 0 5

Download Image

Mark Meiselbach @Mark_Meiselbach

4 years ago

I thought health economics deserved its own... let me know what I missed! No shade meant for any of these papers, of course. #healthecon Original source of comic: xkcd.com/2456/

20 96 417 0 33

Download Image

Dan Gorenstein @dmgorenstein

4 years ago

A quick thread on our new @tradeoffspod episode out today about the HIV prevention pill PrEP. It’s a story of the best and worst of the US drug system in one drug. 1/ tradeoffs.org/2021/04/22/pre…

1 17 26 0 8

Meg Tirrell @megtirrell

4 years ago

FDA should have led J&J #covid19 vaccine decision-making, former commissioner @ScottGottliebMD writes in @WSJ. “Putting the issue before the CDC confused the process and slowed the decision.” wsj.com/articles/drug-…

14 66 319 0 6

Amitabh Chandra @amitabhchandra2

4 years ago

"Imagine if AstraZeneca and Merck were the only ones who had taken up the vaccine challenge...We’d be screwed.” @DhruvKhullar dazzles in @NewYorker newyorker.com/science/annals…

0 7 26 0 3

Nicholas Bagley @nicholas_bagley

4 years ago

“When it comes to something like vaccines, you don’t want the best deal,” he said. “You don’t want to pay the minimum price. You want to overpay and attract the attention of many companies simultaneously.” @amitabhchandra2 speaking truth: newyorker.com/science/annals…

0 4 25 0 3

Amitabh Chandra @amitabhchandra2

5 years ago

A+

Dr. Glaucomflecken @DGlaucomflecken

5 years ago

A+

394 2K 17K 0 433

Download Video

0 0 7 0 2

Tradeoffs @tradeoffspod

5 years ago

3. In @JAMA_current, @jgrischkan @AriBFriedman and @amitabhchandra2 suggest the best way to fix medical education is to change how it's financed: doi.org/10.1001/jama.2…

0 4 6 0 2

Atul Gawande @Atul_Gawande

5 years ago

The strong Novavax results in UK - 90% overall effectiveness; 96% w original COVID; 86% w #B117 - indicate we will soon get a 4th vaccine. Amazing. And it adds extra insurance to Biden’s promise to have enough vaccine for all US adults by end of May. novavax.com/sites/default/…

14 208 730 0 14

Download Image

Sarah Kliff @sarahkliff

5 years ago

Hero work from @sangerkatz, who combed through the stimulus bill to explain all the new options for health insurance different people will become eligible for. nytimes.com/2021/03/12/ups…

3 49 88 0 11

Peter Hull @instrumenthull

5 years ago

I don't really know what this means but it sounds cool

ra¢hel @rachdele

5 years ago

I don't really know what this means but it sounds cool

25 272 3K 0 85

4 9 117 0 4

Ziad Obermeyer @oziadias

5 years ago

These behind-the-scenes vetoes happen without patient consent: current and future cancer patients (ie, many of us) would not agree this is in our best interest

Vincent Rajkumar @VincentRK

6 years ago

These behind-the-scenes vetoes happen without patient consent: current and future cancer patients (ie, many of us) would not agree this is in our best interest

3 75 180 0 60

1 2 18 0 1

Michael Chernew @Michael_Chernew

5 years ago

@UM_VBID told me that my earlier tweet about the 2021 vbid summit vbidcenter.org/2021-virtual-v… would not get as many likes as the tweet by @PatrickConwayMD. He was right. So I try again by tagging @amitabhchandra2, whose twitter reach dwarfs mine

0 3 6 0 1

Ray Fisman @RFisman

5 years ago

@mattkahn1966 To reprise a relevant comment from Don Rubin on this topic: It's easy to signal mathematical aptitude but hard to convey wisdom; we conflate the two, which are not at all the same, even though we care mostly about the latter.